Trials / Completed
CompletedNCT05958589
Caudal Block for Inguinal Hernioplasty in Children
Efficacy and Safety of General Anesthesia With Caudal Block for Inguinal Hernioplasty in Children: a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- University of Novi Sad · Academic / Other
- Sex
- Male
- Age
- 3 Years – 5 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, randomized, controlled clinical study designed to determine the effectiveness of caudal block combined with general anesthesia in providing intra- and postoperative analgesia, and its effect on hemodynamic stability and drug consumption.
Detailed description
This prospective, randomized, controlled clinical study will include 70 boys aged 3-5 years scheduled for inguinal herniorrhaphy. Participants will be randomized in 1:1 ratio into two groups. The first group will receive general anesthesia for surgery, while the second group will receive general anesthesia in combination with caudal block. Postoperative pain, hemodynamic parameters and total consumption of all medicaments in the perioperative period will be monitored. Complications and side effects of drugs will be observed as well.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caudal block with levobupivacaine | After the introduction of general anesthesia, a single shot caudal block will be performed with levobupivacaine 0.25% (2.5 mg/kg; maximal dose 75 mg). |
| DRUG | General anesthesia | On the day of operation all patients will recieve midazolam 0.5 mg/kg (maximum dose 15 mg) orally. Induction of anesthesia will be the same for all patients and consist of intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg). The airway will be obtained by placing a laryngeal mask (I-gel®). |
| PROCEDURE | Inguinal hernioplasty | Elective inguinal hernioplasty |
Timeline
- Start date
- 2022-01-08
- Primary completion
- 2024-07-20
- Completion
- 2024-07-20
- First posted
- 2023-07-24
- Last updated
- 2024-12-04
Locations
1 site across 1 country: Serbia
Source: ClinicalTrials.gov record NCT05958589. Inclusion in this directory is not an endorsement.